You are invited to our complimentary dinner symposia!

On-site Registration Only. Limited Attendance. AMA PRA Category 1 CreditsTM Available.

Sponsored by Mayo Clinic Division of Cardiovascular Diseases

Gripping Cases and Venous Interventions: Newest Therapies for Pearls and Perils of the Valve and Structural Other Circulation Heart Disease Session Chairs: Charles J. Bruce M.D. Session Chair: Robert D. McBane, M.D. and Rakesh M. Suri, M.D., D.Phil.

Friday, March 13, 2015 Hard Rock Hotel San Diego, Legends Ballroom, 2nd Floor 6:00 – 7:00 p.m. On-site Registration and Dinner 7:00 – 9:00 p.m. Program

This educational activity is not part of ACC.15; however, the content was reviewed and approved by the ACC.15 Program Committee.

LEARN. ADVANCE. CONNECT.

For information regarding our education Booth 2913 programs and other resources

Booth 3009 Education Self-Study Programs ce.mayo.edu Gripping Cases and Newest Therapies Venous Interventions: Pearls and for Valve and Structural Heart Disease Perils of the Other Circulation Friday, March 13, 2015 Friday, March 13, 2015 6:00 p.m. Registration & Dinner • 7:00 – 9:00 p.m. Program 6:00 p.m. Registration & Dinner • 7:00 – 9:00 p.m. Program Session Chairs: Charles J. Bruce M.D. & Rakesh M. Suri, M.D., D.Phil. Session Chair: Robert D. McBane, M.D. Location: Hard Rock San Diego, Legends Ballroom, Second Floor Location: Hard Rock San Diego, Legends Ballroom, Second Floor

COURSE DESCRIPTION: Since the prevalence of valve disease COURSE DESCRIPTION: The learner will be taken through the and other structural heart diseases is increasing there is an spectrum of venous interventions including re-opening occluded important need to educate providers regarding new approaches, venous channels and ablation of diseased venous segments. intervention and timing of treatment. This program will help you Procedural approaches, clinical pearls, and difficult conundrums evaluate your patients with structural heart disease will be reviewed. While venous diseases are rarely considered integrating the latest diagnostic, interventional, and surgical by practicing cardiologists, the disease burden of this side of techniques into patient treatment plans. the circulation numerically outweighs arterial disease prevalence. Thoughtful management for these diseases falls within the TARGET AUDIENCE: Cardiologists (intervention/non- knowledge base spectrum for practicing cardiovascular specialists. intervention), cardiac surgeons, internists, imaging specialists, cardiovascular fellows, nurses, and physician assistants with roles TARGET AUDIENCE: Cardiologists and in the diagnosis, assessment, understanding, and management of specialists, physician assistants, nurse practitioners, nurses, valvular and structural heart disease. and allied health care providers interested in peripheral vascular disease.

OBJECTIVES UPON CONCLUSION OF THIS PROGRAM: OBJECTIVES UPON CONCLUSION OF THIS PROGRAM: • Describe current strategies for mitral valve intervention • Recognize the appropriate evaluation and management of • Assess the need for aortic valve intervention for aortic patients with inferior and superior vena caval obstruction • Recognize appropriate patients with hypertrophic • Define an appropriate evaluation and treatment strategy for cardiomyopathy suitable for surgical myectomy upper extremity axillary-subclavian venous • Describe timing and type of aortic intervention in patients with • List the available interventions for acute “massive” and Marfan syndrome “submassive” pulmonary • Determine which patients with iliofemoral DVT should undergo PROGRAM AGENDA invasive mechanical thrombolytic therapy 6:00 p.m. On-site Registration and Dinner • Identify the appropriate evaluation and treatment of varicose 6:55 p.m. Welcome and Introduction including saphenous ablation and sclerotherapy Drs. Charles Bruce and Rakesh Suri PROGRAM AGENDA 7:00 p.m. Aortic Stenosis: Bioprosthesis, Mechanical 6:00 p.m. On-site Registration and Dinner or an Aortic Transcatheter Valve? 6:55 p.m. Welcome and Introduction Sunil V. Mankad, M.D. Robert D. McBane, M.D. 7:00 p.m. Vena Caval Occlusion: Endovascular Therapy 7:20 p.m. Robotic Mitral Valve Repair: Is This Right For Haraldur Bjarnason, M.D. Your Patient? 7:10 p.m. Vena Caval Occlusion: Surgical Therapy Hector I. Michelena, M.D. Thomas C. Bower, M.D. 7:40 p.m. Transcatheter Mitral Valve Edge-to-Edge Repair: 7:20 p.m. May Thurner Syndrome When Should You Consider? Jeremy L. Friese, M.D. Charanjit S. Rihal, M.D. 7:30 p.m. Antithrombotic Therapy Following Venous Stenting Waldemar E. Wysokinski, M.D. 8:00 p.m. Hypertrophic Cardiomyopathy: Which Therapy 7:40 p.m. Round Table Discussion and When? Drs. Bjarnason, Bower, Friese and Wysokinski Jeffrey B. Geske, M.D. 8:00 p.m. Submassive : Risk Stratification and Management 8:20 p.m. Marfan Syndrome and Aortic Disease: Amy W. Pollak, M.D. When Should You Spare the Aortic Valve? 8:10 p.m. Catheter-Based Management of “Massive PE” Alberto Pochettino, M.D. Haraldur Bjarnason, M.D. 8:40 p.m. Prosthetic Valve Dysfunction: How to Assess and 8:20 p.m. Novel Anticoagulants for Venous Manage Thromboembolism: What Do the Trials Tell Us Sorin V. Pislaru, M.D., Ph.D. Fadi E. Shamoun, M.D. 8:30 p.m. Caval Filters Gone Bad! 9:00 p.m. Adjourn Jeremy L. Friese, M.D. 8:40 p.m. Round Table Discussion Expert Panel: Drs. Vuyisile Nkomo, Rick Nishimura, Heidi Connolly, Drs. Pollak, Bjarnason, Shamoun, and Friese Charles Bruce, and Rakesh Suri 9:00 p.m. Adjourn

CREDIT FOR EACH COURSE: Mayo Clinic College of Medicine is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Mayo Clinic College of Medicine designates this live activity for a maximum of 2.0 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity. MC4111-168